JONATHAN JAY MAZELSKY - 11 Jul 2025 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Role
Director
Signature
/s/ Jessica Causey, Attorney-in-Fact for Jonathan Jay Mazelsky
Issuer symbol
XRAY
Transactions as of
11 Jul 2025
Net transactions value
+$1,215
Form type
4
Filing time
15 Jul 2025, 16:47:59 UTC
Previous filing
02 Jul 2025
Next filing
08 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MAZELSKY JONATHAN JAY Director C/O DENTSPLY SIRONA INC, 13320-B BALLANTYNE CORPORATE PLACE, CHARLOTTE /s/ Jessica Causey, Attorney-in-Fact for Jonathan Jay Mazelsky 15 Jul 2025 0001556270

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XRAY Common Stock Award $0 +279 +1% $0.000000 28,092 11 Jul 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XRAY Phantom Stock (Directors' Deferred Compensation) DDC Award $1,215 +75 +0.82% $16.20 9,234 11 Jul 2025 Common Stock 75 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
F2 Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director.
F3 Comprised of phantom stock acquired as a result of accrued dividends.

Remarks:

Exhibit 24 - Power of Attorney